XINT.ST
Xintela AB
Price:  
0.26 
SEK
Volume:  
467,151.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XINT.ST Relative Valuation

-887.0%
Upside

As of 2024-12-11, the Relative Valuation of Xintela AB (XINT.ST) is (2.08) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.26 SEK, the upside of Xintela AB based on Relative Valuation is -887.0%.

The range of the Relative Valuation is (1.68) - (2.19) SEK.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.3x - 30.9x 30.7x
Forward P/E multiples 21.1x - 30.4x 27.0x
Fair Price (1.68) - (2.19) (2.08)
Upside -736.7% - -928.2% -887.0%
0.26 SEK
Stock Price
(2.08) SEK
Fair Price

XINT.ST Relative Valuation - Historical P/E Data

Date P/E
2024-11-29 -4.39
2024-11-28 -4.36
2024-11-27 -4.44
2024-11-26 -4.53
2024-11-25 -4.50
2024-11-22 -4.80
2024-11-21 -4.89
2024-11-20 -4.89
2024-11-19 -4.55
2024-11-18 -5.00
2024-11-15 -4.78
2024-11-14 -4.72
2024-11-13 -4.67
2024-11-12 -4.69
2024-11-11 -4.64
2024-11-08 -4.33
2024-11-07 -4.50
2024-11-06 -5.05
2024-11-05 -5.00
2024-11-04 -5.14
2024-11-01 -5.80
2024-10-31 -5.86
2024-10-30 -5.94
2024-10-29 -6.17
2024-10-28 -6.39
2024-10-25 -6.14
2024-10-24 -6.05
2024-10-23 -6.36
2024-10-22 -6.64
2024-10-21 -6.47
2024-10-18 -6.55
2024-10-17 -6.42
2024-10-16 -6.36
2024-10-15 -6.72
2024-10-14 -6.86
2024-10-11 -6.58
2024-10-10 -6.39
2024-10-09 -6.36
2024-10-08 -6.39
2024-10-07 -6.39
2024-10-04 -5.92
2024-10-03 -6.08
2024-10-02 -6.53
2024-10-01 -6.50
2024-09-30 -6.67
2024-09-27 -6.53
2024-09-26 -6.36
2024-09-25 -6.55
2024-09-24 -6.72
2024-09-23 -6.69